Straits Times Index
3,255.54 +16.51 (+0.51%) S&P 500
3,971.27 -6.26 (-0.16%) Dow
32,394.25 -37.83 (-0.12%) Nasdaq
11,716.08 -52.76 (-0.45%) Bitcoin USD
27,299.14 +228.24 (+0.84%) CMC Crypto 200
599.08 +356.40 (+146.86%)
ABBV Jun 2023 145.000 call
| Previous close | 15.95 |
| Open | 15.65 |
| Bid | 15.55 |
| Ask | 15.75 |
| Strike | 145.00 |
| Expiry date | 2023-06-16 |
| Day's range | 15.45 - 15.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 3.39k |
- Motley Fool
2 Relatively Safe Dividend Stocks You Won't Regret Owning
While there's no ironclad method for picking perfectly safe stocks, thankfully there are a few dividend-paying companies that are a bit less risky than average -- as a result of their history of effective competition and their management's skill at executing their business models. Both of the stocks I'll review in a moment are likely to keep growing and paying their shareholders for a very long time, and that means you aren't likely to regret making a purchase. When it comes to appealing biopharma dividend stocks that investors can depend on, AbbVie (NYSE: ABBV) is near the top of the list.
- Motley Fool
This Is the Best Dividend ETF You Can Buy
The Schwab U.S. Dividend ETF (NYSEMKT: SCHD) just went through its annual reconstitution, meaning the top positions look different than they did just a few weeks prior. AbbVie (NYSE: ABBV) is now the fund's largest weighted position.
- CNW Group
CIBC introduces additional Canadian Depositary Receipts ("CDRs")
CIBC today announced the addition of six new Canadian Depositary Receipts ("CDRs"), now listed on the NEO Exchange.
